The EPS miss and widening net loss reinforce the company's cash-burn trajectory against a negligible revenue base. With a $4M market cap and going-concern risk, the stock is highly speculative and likely to remain under pressure. Monitor for any financing or partnership announcements that could extend the cash runway.
Price Chart
Executive Summary
Sixty Degrees Pharmaceuticals reported Q1 2026 revenue of $162K (down ~1% YoY) and a net loss of $1.28 per share, significantly missing the consensus EPS estimate of -$0.99. The company continues to burn cash with operating expenses of $2.17M against minimal revenue, and the going-concern warning in the forward-looking statements underscores persistent financial distress.
Key Financial Metrics
Key Facts
- Q1 2026 net product revenue of ~$162K, down ~1% from $164K in Q1 2025
- EPS of -$1.28 missed consensus estimate of -$0.99 by 29.3%
- Net loss of ~$2.21M vs ~$2.00M in Q1 2025, widening 10.5%
- Gross profit fell to ~$76K from $90K in the prior-year quarter
- Operating expenses increased to ~$2.17M from ~$2.09M
- Going-concern risk reiterated in forward-looking statements
Financial Impact
EPS miss of 29.3% on consensus -$0.99; revenue essentially flat at $162K; net loss widened by ~$210K
Risk Factors
- Going-concern risk — cash burn exceeds revenue by >10x
- No near-term catalyst for revenue inflection
- Low market cap ($4M) amplifies volatility and delisting risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3295850 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.8759 | awaiting T+5 | — | $0.8700 (−0.67%) |
Oct 6, 2026 20d ago | Press Release | $1.11 $0.9000 | ▼ −18.92% | ▼ −18.78% | $0.8700 (−21.62%) |
Oct 6, 2026 20d ago | 8-K | $1.11 $0.9000 | ▼ −18.92% | ▼ −18.78% | $0.8700 (−21.62%) |
Aug 26, 2026 8w ago | EFFECT | $1.08 $0.9495 | ▲ +12.08% | ▲ +11.96% | $0.8700 (+19.44%) |
Aug 14, 2026 10w ago | Press Release | $1.20 $1.13 | ▲ +5.44% | ▲ +4.07% | $0.8700 (+27.20%) |
Jul 30, 2026 12w ago | Press Release | $1.25 $1.15 | ▲ +8.00% | ▲ +11.62% | $0.8700 (+30.40%) |
Jul 1, 2026 16w ago | Press Release | $1.75 $1.55 | ▼ −11.43% | ▼ −11.38% | $0.8700 (−50.29%) |
May 26, 2026 21w ago | Press Release | $1.50 $1.46 | ▼ −2.67% | ▼ −3.75% | $0.8700 (−42.00%) |
May 15, 2026 23w ago | Press Release | $1.39 $1.48 | ▼ −6.47% | ▼ −5.51% | $0.8700 (+37.41%) |
Mar 31, 2026 29w ago | Press Release | $1.75 $1.81 | ▲ +3.43% | ▼ −0.52% | $0.8700 (−50.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers